6143 POSTER Study 20050203/PRIME – Effect of Post-Progression Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (mAb) Therapy in Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC)

Saved in:
Bibliographic Details
Title: 6143 POSTER Study 20050203/PRIME – Effect of Post-Progression Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (mAb) Therapy in Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC)
Authors: Siena, S., Douillard, J.Y., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M.E., Humblet, Y., Cunningham, D., Yu, H., Krishnan, K.
Source: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS435-S435. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(11)71788-9